FDA removing warning labels from some hormone replacement therapy medication

FDA removing warning labels from some hormone replacement therapy medication

More changes are coming from the Food and Drug Administration as officials move to get rid of warning labels on some medications.

Medical Experts Tell FDA To End Testosterone Restrictions, Says TRT Risks Were Overstated

Medical experts are urging the FDA to remove remaining restrictions on testosterone replacement therapy while arguing that decades of safety concerns were overstated and are not supported by modern evidence. During a landmark FDA expert panel on testosterone therapy leading physicians and researchers presented data showing that low testosterone represents a widespread but under-recognized health issue affecting millions of American men. The pane…